REFERENCES
- Bouchaud, O., Basco, L. K., Gillotin, C., Gimenez, F., Ramiliarisoa, O., Genissel, B., Bouvet E., Farinotti, R., Le Bras, J. & Coulaud, J. P. (1994). Clinical efficacy and pharmacokinetics of micronized halofantrine for the treatment of acute uncomplicated falciparum malaria in nonimmune patients. American Journal of Tropical Medicine and Hygiene, 51, 204–213.
- Bryson, H. M. & Goa, K. L. (1992). Halofantrine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic potential. Drugs, 43, 236–258.
- Fadat, G., Lewis, J. P. & Le Bras, J. (1993). Efficacy of micronized halofantrine in semi-immune patients with acute uncomplicated falciparum malaria in Cameroon. Antimicrobial Agents in Chemotherapy, 37, 1955–1957.
- Gillespie, S. H., Msaki, E. P., Ramsay, A. R. C., Ngowi, F. I. & Fox, R. (1993). A new micronized formulation of halofantrine in the treatment of acute malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 87, 467–469.
- Horton, R. J., Parr, S. N & Bokor, L. K. (1990). Clinical experience with halofantrine in the treatment of malaria. Drugs under Experimental and Clinical Research, 16, 497–503.
- Karbwang, J., Milton, K. A., Na Bangchang, K., Ward, S. A., Edwards, G. & Bunnag, D. (1991). Pharmacokinetics of halofantrine in Thai patients with acute uncomplicated falciparum malaria. British Journal of Clinical Pharmacology, 31, 484–487.
- Karbwang, J. & Na Bangchang, K. (1994). Clinical pharmacokinetics of halofantrine. Clinical Pharmacokinetics, 27, 104–119.
- Kremsner, P. G., Wildling, E., Jenne, L., Graninger, W. & Bienzle, U. (1994). Comparison of micronized halofantrine with chloroquine-antibiotic combinations for treating Plasmodium falciparum malaria in adults from Gabon. American Journal of Tropical Medicine and Hygiene, 50, 790–795.
- Nosten, F., Ter Kuile, F. O., Luxemburger, C., Woodrow, C., Kyle, D. E., Chongsuphajaisiddhi, T. & White, N. J. (1993). Cardiac effects of antimalarial treatment with halofantrine. Lancet, i, 1054–1056.
- Ramsay, A. R. C., Moreno-Altamirano, B., Suvari, M. M., Kennedy, N., Voller, A., Wilson, S. & Gillespie, S. H. (1993). Comparison of an antigen detection ELISA with a non-radiometric DNA hybridization technique for the diagnosis of Plasmodium falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 87, 373.
- Suvari, M. M., Kennedy, N., Msaki, E. P., Ramsay, A., Bidwell, D., Voller, A. & Gillespie, S. H. (1993). Clinical evaluation of an antigen detection ELISA for Plasmodium falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 87, 375.
- Ter Kuile, F. O., Dolan, G., Nosten, F., Edstein, M. D., Luxemburger, C., Phaipun, L., Chongsuphajaisiddhi, T., Webster, H. K. & White, N. J. (1993). Halofantrine versus mefloquine in treatment of multidrug-resistant falciparum malaria. Lancet, i, 1044–1049.
- Toivonen, L., Viitasalo, M., Siikamaki, H., Raatikka, M. & Pohjola-Sintonen, S. (1994). Provocation of ventricular tachycardia by antimalarial drug halofantrine in congenital long QT syndrome. Clinical Cardiology, 17, 403–404.
- Touze, J. E., Peyron, F., Mojon, M. & Fourcade, L. (1995). Halofantrine: for new rules of prescription. Presse Médicale, 24, 366–369.
- Wildling, E., Jenne, L., Graninger, W., Bienzle, U. & Kremsner, P. G. (1994). High dose chloroquine versus micronized halofantrine in chloroquine-resistant Plasmodium falciparum malaria. Journal of Antimicrobial Chemotherapy, 33, 871–875.